Skip to main content
Premium Trial:

Request an Annual Quote

Michael Hanbury

Acuamark Diagnostics has appointed Michael Hanbury to its board of directors. Hanbury is currently a healthcare advisor for the Pritzker Group and is on a number of medical device company boards. Previously, he served as VP of laboratory operations and laboratory excellence for Quest Diagnostics, and president and chief operating officer at Solstas Lab Partners. Earlier in his career he served as president and CEO of DCL Medical Laboratories, and as executive VP of operations and CSO at Unilab.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.